Published in Blood Weekly, January 20th, 2005
According to recent research from the United States, "Human embryonic stem cells (ESCs) have generated enormous interest due to their ability to self-renew and produce many different cell types.
In conjunction with microarray technology, human ESCs provide a powerful tool for employing a systems-based approach to deciphering the molecular mechanisms that control pluri-potency and early development. Recent work has focused on defining 'stemness' and pluripotency based on different experimental and analytical approaches in both mouse and human ESCs."
"Using a mixed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.